Impact of Glycemic Variability on People With Gastrointestinal Cancer and Diabetes After Surgery

NAActive, not recruitingINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

September 8, 2025

Primary Completion Date

July 31, 2028

Study Completion Date

July 31, 2028

Conditions
Diabetes MelletusGastrointestinal Cancers
Interventions
BEHAVIORAL

CARE program

The CARE program is an 8-week intervention using reflection assisted with CGM. The Abbott factory-calibrated Freestyle Libre Flash Glucose Monitoring (Freestyle Libre 2) system will be used to evaluate glycemic variability.

OTHER

Usual Care

Usual care means the participants will receive care from their primary care physicians and nurses during clinic visits at the surgical OPD.

Trial Locations (1)

Unknown

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER